T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor

Thymus-derived lymphocytes (T cells) exert their regulatory effect (help or suppression) on the antibody production by B cells either by direct cell to cell interaction or by soluble mediators or factors. The low frequency of specific T cells, the heterogeneity of their responses and their relatively short life span have hampered the molecular characterization of the antigen recognition unit of T cells, and its structure is largely unknown. The lymphocyte hybridization technique, which has been found very useful for the production of B-cell hybridomas secreting specific monoclonal antibodies, has also been used for the generation of homogeneous and stable T-cell hybridomas with unlimited growth potential. So far the only specific effector function demonstrated in the established T hybridomas is the property to generate a factor(s) which suppresses antibody responses. We now describe the establishment of hybrid lines which exhibit characteristic T-cell markers. One of the hybridomas (denoted R-9) releases into the culture supernatant factor(s) with helper activity specific to the synthetic polypeptide (T,G)-A--L and bears surface determinants of the immunoglobulin heavy chain variable region (VH). Such hybrid cell lines are of great value for studies on the nature of the T-cell receptor.     

ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation

Geleophysic dysplasia is an autosomal recessive disorder characterized by short stature, brachydactyly, thick skin and cardiac valvular anomalies often responsible for an early death. Studying six geleophysic dysplasia families, we first mapped the underlying gene to chromosome 9q34.2 and identified five distinct nonsense and missense mutations in ADAMTSL2 (a disintegrin and metalloproteinase with thrombospondin repeats-like 2), which encodes a secreted glycoprotein of unknown function. Functional studies in HEK293 cells showed that ADAMTSL2 mutations lead to reduced secretion of the mutated proteins, possibly owing to the misfolding of ADAMTSL2. A yeast two-hybrid screen showed that ADAMTSL2 interacts with latent TGF-beta-binding protein 1. In addition, we observed a significant increase in total and active TGF-beta in the culture medium as well as nuclear localization of phosphorylated SMAD2 in fibroblasts from individuals with geleophysic dysplasia. These data suggest that ADAMTSL2 mutations may lead to a dysregulation of TGF-beta signaling and may be the underlying mechanism of geleophysic dysplasia.     

A new genus and four new species of onchidiid slugs from South-East Asia (Mollusca: Gastropoda: Pulmonata: Onchidiidae)

The taxonomy of the Onchidiidae has remained extremely confusing for decades. As part of an on-going systematic revision of the entire family, a new genus, Melayonchis Dayrat and Goulding gen. nov., and four new species (Melayonchis eloisae Dayrat sp. nov., Melayonchis siongkiati Dayrat and Goulding sp. nov., Melayonchis annae Dayrat sp. nov., and Melayonchis aileenae Dayrat and Goulding sp. nov.) are described. Species are delineated using an integrative approach, based on morphological characters and DNA sequences. First-hand field observations and pictures of live animals are provided in order to help future species identification. All four Melayonchis species live in mangrove forests. The geographic distribution of Melayonchis ranges from the Andaman Sea to the South China Sea through the Strait of Malacca. Records are based on entirely new collections from the Andaman Islands, Peninsular Malaysia, Singapore, Brunei Darussalam and Vietnam. The nomenclature of all existing onchidiid species- and genus-group names from that region is addressed, as well as intraspecific character variation within Melayonchis.

www.zoobank.org/urn:lsid:zoobank.org:pub:671922DB-C6C1-44A5-B2CD-A3A3127CB668     

Potential of stem-cell-based therapies for heart disease

The use of stem cells to generate replacement cells for damaged heart muscle, valves, vessels and conduction cells holds great potential. Recent identification of multipotent progenitor cells in the heart and improved understanding of developmental processes relevant to pluripotent embryonic stem cells may facilitate the generation of specific types of cell that can be used to treat human heart disease. Secreted factors from circulating progenitor cells that localize to sites of damage may also be useful for tissue protection or neovascularization. The exciting discoveries in basic science will require rigorous testing in animal models to determine those most worthy of future clinical trials.     

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported previously that cardiac fibroblasts,which represent 50%of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here we use genetic lineage tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became binucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast-activating peptide, thymosin b4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.     

印度喜马偕尔邦两种松树根际线虫新种

描述了来自印度喜马偕尔邦的两种松树根际线虫新种。线虫新种Ogma varispinosum sp.n.， 分离自喜马拉雅长叶松(Pinus roxburghii Sarg.)，雌虫特征：L(体长)=0.41~0.46 mm;a(体长/最 大体宽)=10.5~12.7;b(体长/体前端至食道与肠连接处的距离)=3.2~3.5;c(体长/尾长)=11.0~13.4;c ′(尾长/肛门处体宽)=1.3~2.3;V(阴门至头顶距离×100/体长)=83.9 %~85.7 %;Stylet(口针长)为 86~88 μm;R(体环数)为77~81;Res(唇盘与贲门瓣之间的体环数)为23~25;RV(阴门与尾端之间的体环 数)=12~13;RV-an(肛门与阴门之间的体环数)=4~6;8~9纵行的鳞片，第1行为环纹形状。另一线虫新 种O.ornamentum sp.n，分离自乔松(P.wallichiana A.B.Jacks)。雌虫特征：L=0.31~037 mm;a=8.2~11.6;b=3.2~3.8;c=6.8~8.5;V=82.0 %~84.9 %;Stylet为69.9~72.0 μm;R=59~62;Res=16~18;Rex=20;RV=11~12;RV-an=1~2;具有特殊的表皮结构。     

Catalytic performance of nano-hybrid graphene and titanium dioxide modified cathodes fabricated with facile and green technique in microbial fuel cell

Finite resources of the world''s fossil fuel give rise to the irresistible urge to explore alternative renewable energy routes such as microbial fuel cells (MFCs). The limited productivity is one of the main obstacles for MFC scalability. In this study, a dual-chamber MFC was assembled and equipped with fabricated modified cathodes with titanium dioxide (TiO2) or hybrid graphene (HG) which mainly improved the catalytic activity of the cathode. The graphite paste (GP) bare electrode was modified by both nanomaterials using a green and facile technique. The results showed that the modified cathodes resulted in a considerable improvement for the MFC performance, i.e., the power density reaching levels of 80 mW/m2 for GP-TiO2 and 220 mW/m2 for GP-HG compared to 30 mW/m2 for GP electrode. Additionally, the modified electrodes exhibited lower charge transfer resistance (Rct) compared to the bare electrode. Therefore, these modified electrodes, fabricated by an eco-friendly method, could be used as alternatives to the precious expensive metals like Pt.